Learn About Blood Clots

What is the definition of Blood Clots?

Blood clots are clumps that occur when blood hardens from a liquid to a solid.

  • A blood clot that forms inside one of your veins or arteries is called a thrombus. A thrombus may also form in your heart.
  • A thrombus that breaks loose and travels from one location in the body to another is called an embolus.

A thrombus or embolus can partly or completely block the flow of blood in a blood vessel.

  • A blockage in an artery may prevent oxygen from reaching the tissues in that area. This is called ischemia. If ischemia is not treated promptly, it can lead to tissue damage or death.
  • A blockage in the vein will often cause fluid buildup and swelling in the area where blood is drained by that vein.
What are the alternative names for Blood Clots?

Clot; Emboli; Thrombi; Thromboembolus; Hypercoagulable state

What are the causes of Blood Clots?

Situations in which a blood clot is more likely to form in veins include:

  • Being on long-term bed rest
  • Sitting for long periods, such as in a plane or car
  • During and after pregnancy
  • Taking birth control pills or estrogen hormones (especially in women who smoke)
  • Long-term use of an intravenous catheter
  • After surgery

Blood clots are also more likely to form after an injury. People with cancer, obesity, and liver or kidney disease are also prone to blood clots.

Smoking also increases the risk of forming blood clots.

Conditions that are passed down through families (inherited) may make you more likely to form abnormal blood clots. Inherited conditions that affect clotting are:

  • Factor V Leiden mutation
  • Prothrombin G20210A mutation

Other rare conditions, such as protein C, protein S, and antithrombin III deficiencies.

A blood clot may block an artery or vein in an organ, affecting the:

  • Heart (angina or a heart attack)
  • Intestines (mesenteric ischemia or mesenteric venous thrombosis)
  • Kidneys (renal vein thrombosis)
  • Leg or arm arteries
  • Legs (deep vein thrombosis)
  • Lungs (pulmonary embolism)
  • Neck or brain (stroke)
Who are the top Blood Clots Local Doctors?
Keiji Nogami
Elite in Blood Clots
Elite in Blood Clots
Kashihara-shi, JP 

Keiji Nogami practices in Kashihara-shi, Japan. Mr. Nogami is rated as an Elite expert by MediFind in the treatment of Blood Clots. His top areas of expertise are Hemophilia A, Blood Clots, Acquired Hemophilia, Synovectomy, and Adenoidectomy.

Alok Srivastava
Elite in Blood Clots
Internal Medicine
Elite in Blood Clots
Internal Medicine

Aurora Internal Medicine

818 Forrest Ln, 
Waterford, WI 
Languages Spoken:
English

Alok Srivastava is a primary care provider, practicing in Internal Medicine in Waterford, Wisconsin. Dr. Srivastava is rated as an Elite provider by MediFind in the treatment of Blood Clots. His top areas of expertise are Hemophilia A, Blood Clots, Beta Thalassemia, Bone Marrow Aspiration, and Endovascular Embolization.

 
 
 
 
Learn about our expert tiers
Learn More
Christine L. Kempton
Elite in Blood Clots
Elite in Blood Clots

Emory Hemophilia Of Georgia

550 Peachtree Street Northeast, MedicalOfficeTower, 
Atlanta, GA 
Experience:
28+ years
Languages Spoken:
English
Offers Telehealth

Christine Kempton is a Hematologist in Atlanta, Georgia. Dr. Kempton has been practicing medicine for over 28 years and is rated as an Elite provider by MediFind in the treatment of Blood Clots. Her top areas of expertise are Hemophilia A, Blood Clots, Hemophilia B, Von Willebrand Disease (VWD), and Bone Marrow Aspiration.

What are the latest Blood Clots Clinical Trials?
A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease

Summary: The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have been previously treated with VWF product or with a plasma-derived VWF (pdVWF) product. In this study, participants will be treated with vonicog alfa (rVWF) for 12 months. During the study, participan...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)

Summary: This phase II trial compares the effect of ASTX727 in combination with iadademstat to ASTX727 alone in treating patients with accelerated or blast phase Philadelphia chromosome negative myeloproliferative neoplasms (MPNs). ASTX727 is a combination of two drugs, cedazuridine and decitabine. Cedazuridine is in a class of medications called cytidine deaminase inhibitors. It prevents the breakdown of ...

Who are the sources who wrote this article ?

Published Date: June 17, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Anderson JA, Weitz JI. Hypercoagulable states. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 138.

Cross SS. Ischaemia, infarction and shock . In: Cross SS, ed. Underwood's Pathology. 7th ed. Philadelphia, PA: Elsevier; 2019:chap 7.

Schafer AI. Approach to the patient with bleeding or thrombosis: hypercoagulable states. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 157.